Paper7166178
Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.
Pentikäinen PJ and 4 others. Eur J Drug Metab Pharmacokinet, 1982. Cited by 14 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites. Papers, record 7166178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7166178
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ortho-Aminobenzoates | Major topic |
| Adult | |
| Biotransformation | |
| Female | |
| Humans | |
| Kinetics | |
| Male | |
| Protein Binding | |
| Time Factors | |
| Tissue Distribution |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02159248 | Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation | Background |
Source ClinicalTrials.gov
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,151,301 | Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. | Eur J Clin Pharmacol | 1971 | https://conductscience.org/library/papers/5151301 | PubMed |
| 2 | 7,238,564 | Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7238564 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,661,084 | Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids. | Pharm Res | 2022 | https://conductscience.org/library/papers/35661084 | PubMed |
| 8,983,935 | Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose. | Eur J Drug Metab Pharmacokinet | 1995 | https://conductscience.org/library/papers/8983935 | PubMed |
| 6,334,608 | Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6334608 | PubMed |
| 3,876,221 | Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3876221 | PubMed |
| 3,758,148 | Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3758148 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7166178
GET https://conductscience.org/api/papers/v1/7166178/authors